Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
Second Edition BOGP (0)
Australia (1)
Access
Musculoskeletal/Multiple Sclerosis (MS) (1)
Biotech Company (0)
Payers (usually governmental or public bodies, reimbursement)
Shared purpose
Clinical study phase III